A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.
Clinical trial NCT03681548 · COMPLETED
Trial details
- NCT number
- NCT03681548
- Sponsor
- Ayana Pharma Ltd.,
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-29
- Primary completion
- 2019-02-08
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.